Search for Clinical Trial Results

Sponsored By

Neisseria Meningitidis Infection - 25 Studies Found

Status Study
Completed Study Name: Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.
Condition: Meningococcal Disease
Date: 2014-05-15
Interventions: Biological: rMenB+OMV 2 doses of vaccine 2 months apart
Active, not recruiting Study Name: MenPF-1 - A New Vaccine Against Meningococcal Disease
Condition: Serogroup B Meningococcal Disease
Date: 2012-05-23
Interventions: Biological: MenPF-1. A new vaccine against meningococcal disease.
Completed Study Name: Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months
Condition: Meningococcal Disease
Date: 2008-01-15
Interventions:
  • Biological: MenACWY-CRM197 Blo
Completed Study Name: Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants
Condition: Meningococcal Disease
Date: 2007-02-09
Interventions:
  • Biological: rMenB One dose (0.
Completed Study Name: Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents
Condition: Meningococcal Disease
Date: 2006-02-27
Interventions:
  • Biological: serogroup B meningococcal vaccine

Completed Study Name: Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.
Condition: Meningococcal Disease
Date: 2012-09-07
Interventions: Biological: MenACWY-CRM The investigational meningococcal (groups A, C, Y, and W-135 vaccine) oligosacch
Completed Study Name: Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers
Condition: Meningococcal Disease
Date: 2013-11-11
Interventions:
  • Biological: MenACWY-CRM MenACW
Completed Study Name: Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults
Condition: Meningococcal Disease
Date: 2007-11-16
Interventions:
  • Biological: Men ACWY CRM A sin
Completed Study Name: B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants
Condition: Meningococcal Disease
Date: 2007-06-19
Interventions:
  • Biological: MenACWY-CRM One do
Withdrawn Study Name: A Case-control Study of the Efficacy of a New Serogroup A Meningococcal Conjugate Vaccine (MenAfriVac) in Mali and Niger
Condition: Meningococcal Disease
Date: 2011-02-08
Next >>>